Severe Hunter Syndrome (Mucopolysaccharidosis II) Phenotype Secondary to Large Deletion in the X Chromosome Encompassing IDS,FMR1,and AFF2 ( FMR2 )

Abstract

A 2-year-old boy with an initial diagnosis of Hunter syndrome (mucopolysaccharidosis II) had a more severe phenotype than expected, which warranted further evaluation. The patient had severe infantile global neurodevelopmental delays, macrocephaly with a prominent forehead, coarse facial features with clear corneas, chronic congestion with snoring, wide-spaced teeth, short thick neck, hepatomegaly, an inguinal hernia repaired, early clawhand deformities, and severe generalized hypotonia. X chromosome microarray revealed a large deletion encompassing the genes IDS, FMR1, and AFF2 (FMR2) confirming the diagnoses of both Hunter and fragile X syndromes. This case is also a reminder to clinicians that for optimum patient care, further diagnostic testing is warranted if there is concern that a patient’s phenotype is more severe or complex than would be expected for the initial neurogenetic diagnosis.

Keywords

deletion gene Hunter syndrome Fragile X IDS/FMR1/AFF2

Get full access to this article

View all access options for this article.

References

Neufeld

Muenzer

. The mucopolysaccharidoses. In: Scriver

Beaudet

Sly

, eds. The Metabolic and Molecular Bases of Inherited Disease Volume III. 8th ed. New York: McGraw-Hill; 2001:3421–3452.

Peining

Bellows

Thompson

. Molecular basis of iduronate-2-sulfatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome). J Med Genet. 1999;36:21–27.

Jones

. Smith’s Recognizable Patterns of Human Malformations. 6th ed. Philadelphia: Elsevier Inc; 2006.

Online Mendelian Inheritance in Man (OMIM). Baltimore, MD: Johns Hopkins University. Available at: http://omim.org. Accessed July 28, 2011.

Probst

Roeder

Enciso

. Chromosomal microarray analysis (CMA) detects a large chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation. Am J Med Genet Part A. 2007;143A:1358–1365.

Birot

Delobel

Gronnier

. A 5-megabase familial deletion removes the IDS and FMR1 genes in a male Hunter patient. Hum Mutat. 1996;7:266–268.

Clarke

Wilson

Morris

. Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet. 1992;51:316–322.

Hagerman

. Fragile X Syndrome Diagnosis, Treatment, and Research. 3rd ed. Baltimore, MD: Johns Hopkins University Press; 2002.

Hirst

Fisch

. The fragile X syndrome and the fragile X mutation. In: Fisch

, ed. Genetics and Genomics of Neurobehavioral Disorders. Totowa, NJ: Humana Press; 2003:335–389.

10.

Krueger

Bear

. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu Rev Med. 2011;62:411–429.

11.

Filomena

Tabolacci

Neri

. The FRAXopathies: definition, overview, and update. Am J Med Genet Part A. 2011;155:1803–1816.

12.

Hersh

Saul

Saal

. Clinical report—health supervision for children with fragile X syndrome. Pediatrics. 2011;127:994–1006.

13.

Wells

. Mutation spectra in fragile X syndrome induced by deletions of CGG·CCG repeats. J Biol Chem. 2009;284:7407–7411.

14.

Gecz

Fisch

. Nonsyndromal mental retardation associated with the FRAXE fragile site and the FMR2 gene. In: Fisch

, ed. Genetics and Genomics of Neurobehavioral Disorders. Totowa, NJ: Humana Press; 2003:289–334.

15.

Fengler

Fuchs

Konig

Arnemann

. Mosaicism for FMR1 and FMR2 deletion: a new case. J Med Genet. 2002;39:200–201.